• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Q-MED AB DUROLANE; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Q-MED AB DUROLANE; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Lot Number 20982
Device Problem Use of Device Problem (1670)
Patient Problem Hypersensitivity/Allergic reaction (1907)
Event Type  Injury  
Event Description
Describe event, problem, or product use error: 3 patients in the past couple weeks received injections at scott air force base medical clinic of durolane and had confirmed pseudoseptic reactions.All 3 patients were injected with the same lot (lot 20982 exp 07/31/2025).This is the first time this reaction as been observed in the 3 years this product has been in use at this location.Reference report mw5116878,mw5116879.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DUROLANE
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
Q-MED AB
MDR Report Key16787928
MDR Text Key313863814
Report NumberMW5116877
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 04/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/20/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Lot Number20982
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexPrefer Not To Disclose
-
-